All workers in suits, mixed genders working

Most AI transformations will fail for a familiar reason. Not because the strategy is wrong, but because organisations misread how change actually happens. The recent BCG analysis makes this explicit: leaders...

Brass balance scales on a dark desk, one pan full of gold coins, the other nearly empty but level.

Most IP disputes don’t end in a clean win. They end in a split — you carry some grounds, lose others, and then discover the scoreboard the court actually cares about...

Robot making a shushing gesture to a woman in a dimly lit bar

For two decades, IP protection quietly relied on one assumption: a human in the loop who knew what was confidential, what was privileged, and where a draft came from. Agentic AI...

Open glass vault door in a modern room with light and glowing particles flowing out toward a window. (108 characters)

The most valuable lesson in intellectual property this week wasn’t a single ruling — it was a pattern. Across a landmark licensing deal, a patent that collapsed over one character, and...

Glowing digital padlock on a dark fibre-optic network, with some light pathways severed and others reconnecting around it.

If you hold copyright in music, film, software or any content that pirates love, a court order blocking the offending site is one of the most effective tools you have —...

Engineer walking away with a glowing document of patent drawings, leaving a blue-lit laser clean room behind.

A former engineer leaves, starts a company, and files a patent. Months later the original employer discovers the application describes technology that looks remarkably like a project the engineer worked on...

Two race cars labeled Brand Name Pharma and Generic Competition racing on track near a sign reading Patent Expiration Ahead and a cliff labeled The Drug Patent Cliff

IP Organiser’s recently compiled record of every pharmaceutical patent term extension granted in Australia maps roughly 1,600 extended patents across 850 products, and the patterns are worth reading closely. Activity is...

Business professionals discussing legal risk and defensive tactics around a conference table

Amending the basis of your validity challenge in patent litigation is never just a procedural move — it is a strategic play with real commercial consequences. What stands out in AstraZeneca...

Widening a patent claim is never free. Every limitation you drop to capture more of the market quietly commits you to two things: a disclosure that actually supports the wider claim,...